Aratana Therapeutics IPO Research Information

Aratana Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Aratana Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Aratana Therapeutics	PETX -	$11.00-$13.00	$6.00	$7.00	5.75 million	6/27/2013
Underwriter(s): Stifel, Lazard Capital
Co-Manager(s): William Blair, JMP Securities, Craig-Hallum Capital Group
Industry: Health Care
Filing(s): Filed 2013-03-20

Aratana Therapeutics Quote & Chart - Click for current quote - PETX

About Aratana Therapeutics (adapted from Aratana Therapeutics prospectus):
They are a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics.

This description is adapted from Aratana PETX prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Aratana PETX "PETX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.